Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
$16.77 - $50.89
Next Earnings Date
Apr 30 2025
Next Earnings Date
Apr 30 2025
Latest price
Market Cap | $5.63B |
EV | $6.13B |
Shares Outstanding | 124.71M |
Beta | 1.45 |
Analyst Rating | BUY |
Analyst Target Price | $56.24 |
P/E 2025E | - |
P/Revenue 2025E | 6.57x |
Revenue | 25.50% |
EPS | 22.20% |
Operating Cash Flow | -2.40% |
Free Cash Flow | 1.10% |
Revenue | 20.50% |
EPS | 21.60% |
Operating Cash Flow | 74.00% |
Free Cash Flow | 31.40% |
Gross Margin 2025E | 62.21% |
Net Profit Margin 2025E | -46.59% |
ROE 2025E | -545.18% |
ROCE 2024 | -4584.47% |
DPS 2025E | $0.00 |
Payout Ratio 2025E | 0.00% |
Div. Yield 2025E | 0.00% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Guardant Health, Inc.
GH
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Data Unavailable
Employees
2,010
Website
guardanthealth.comIPO Date
2018-10-04
Headquarters
3100 Hanover Street, Palo Alto, California, 94304, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved